1. Unclear Intellectual Property Rights Baffle Foreign Pharmaceutical R&D Projecting to strike Gold in Chinese market
07-23-2010
With the constant burden of the current financial crisis, the US government and large pharmaceutical companies have decided to tighten spending practices and ease up on biopharmaceutical investments. In the first half of 2010, leaders of the pharmaceutical ...
2. International biological experts gather in Changsha
07-19-2010
The First Overseas High-level Talents Bioceutical Innovation Entrepreneurship Forum and the Fourth Chemical Biology and Innovative Drugs Sino-US Round Table Discussion opened in Changsha in 17th July, gathering the home and abroad top talents in the field ...
3. Dried Blood Spot (DBS) technique will bring ethical, scientific and cost benefits
07-08-2010
Evreux, France, July 8, 2010 - CIT, an independent preclinical contract research organization (CRO), announces today that it is now offering the Dried Blood Spot (DBS) technique to its clients worldwide. The new service is in line with CIT's policy of ...
4. China surpassed United States in bioethanol patent applications and commercialization
07-08-2010
Columbus, Ohio (June, 24, 2010) – Chemical Abstracts Service (CAS), the world's leading authority on chemical information recently disclosed in their report that in 2009 China’s bioethanol patent production has now transcended other countries to emerge ...
5. Bio-nano Cooperation Forum opened on June 23rd, 2010
07-02-2010
Following the series of meetings that took place in April, Suzhou's Dushu Lake once again shines in the life science realm. On June 23rd and 24th, the SIP BioBay, along with ChinaBio and EBD Group, held the 2010 Bio-nano Cooperation Forum. The forum attracted ...
6. FDA advisory committee recommends approval of Novartis’ MS drug
06-11-2010
An advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, according to the company. The committee voted unanimously that FTY720 demonstrated ...
7. GSK acquired a Latin American pharmaceutical company
06-11-2010
GlaxoSmithKline announced that it has acquired Laboratorios Phoenix S.A.C.yF (‘Phoenix’), an Argentine pharmaceutical business, for a cash consideration of approximately $253 million. Under the terms of the transaction, GSK will gain full ownership of ...
8. Genzyme and Carl Icahn Reach Agreement
06-11-2010
Genzyme and Carl C. Icahn and certain of his affiliated private investment funds announced an agreement to settle their proxy contest. Under the agreement, the Icahn funds will withdraw its slate of four nominees for Genzyme’s board of directors and vote ...
9. New Pfizer Chief Scientific Officer for Neuroscience Research
06-11-2010
Pfizer Inc. announced that Michael D. Ehlers, M.D., Ph.D., has joined the company as Chief Scientific Officer for Neuroscience Research. Dr. Ehlers will report to Rod MacKenzie, Ph.D., Senior Vice President and Head of PharmaTherapeutics ...
10. Gene linked to Alzheimer's disease plays key role in cell survival
06-11-2010
Scientists have discovered that a gene linked to Alzheimer's disease may play a beneficial role in cell survival by enabling neurons to clear away toxic proteins. A study funded by the National Institute on Aging (NIA), part of the National Institutes ...
[1] ...